Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6

Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic

The Chinese patients with chronic hepatitis C have a different genetic background, which had been demonstrated to significantly influence their responses to pegylated interferon and ribavirin. In this study, Chinese patients with Hepatitis C Virus genotype 1, 2/3, 6 infection were treated with pegylated interferon and ribavirin. Their response was compared amongst different genotypes.

Inclusion Criteria:

• HCV RNA is positive
• Treatment naive
• Come from China

Exclusion Criteria:

• Active substance abuse
• Poorly controlled psychiatric disease
• HBsAg positive
• Anti-HIV positive
• Suffering from other significant concurrent medical conditions including chronic liver diseases